As I said in my last post, one of the key components of the Map of Biomedicine is how new treatments get developed. That’s one of the parts of the map that is highlighted, as shown below.Read More
Up at 5AM: The 5AM Solutions Blog
It’s finally here: the Map of Biomedicine ebook!
Last year, 5AM’s Chief Science Officer Will FitzHugh started to make notes about the vast -- and expanding -- field for which we develop software: biomedicine. Originally, his purpose was keeping all of the players straight so that he and 5AM’s software development teams could have a big-picture view of the context that our clients work in, as well as details like the regulatory processes and technological shifts that impact human health.Read More
The New York Times reported today that Color Genomics, a Silicon Valley startup has raised $115 million to make a $249 genetic test a reality. The test identifies faulty BRCA, as well as more than a dozen other cancer-related genes. BRCA1 and BRCA2 mutations are responsible for increasing women’s risks for developing certain breast and ovarian cancers. Filmmaker and actress Angelina Jolie has made headlines over the past few years for her decisions to undergo a preventive mastectomy, and more recently, a preventive oophorectomy in response to her own gene-related disease risks.Read More
In my Map of Biomedicine blog posts, so far, I’ve focused on how diagnostics get to market. But you may recall that way back in my first post I discussed the major themes of the map - what I called ‘vignettes’. The first vignette was the development of diagnostic tests, which is what I’ve focused on so far. Those blog posts are being collected and expanded in an e-book which will be released soon, so keep an eye out for that.Read More
Who doesn’t like a scientific breakthrough? The media buzzes with news from the frontiers of science that directly affects us: biological and medical research. The stories that really get our attention are those in which new technologies solve medical mysteries or save lives.